Mast Cell Leukemia: An Update with a Practical Review
Cancers · 08.03.2023 · 15 (6) · 1664
DOI: 10.3390/cancers15061664 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 08.03.2023. Verfasst von Magda Zanelli und 17 weiteren Autor:innen. Beteiligte Einrichtung: Pathology Unit, Azienda USL-IRCCS di Reggio Emilia, 42123 Reggio Emilia, Italy. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Mast cell leukemia (MCL) is the leukemic form of SM with at least 20% mostly immature mast cells on bone marrow aspirate. MCL may develop de novo, in the absence of a prior SM, or it may represent a progression from a previous SM. MCL may be sub-divided into the more frequent, aggressive acute form with signs of organ damage (C-findings) and the chronic form lacking C-findings and presenting a more stable course, although over time, progression to acute MCL is common. The 2022 WHO subtype of MCL with an associated hematological neoplasm was renamed MCL with an associated myeloid neoplasm in the 2022 International Consensus Classification (ICC). The relevance of the distinction between the leukemic and aleukemic forms based on the percentage of circulating mast cells is a matter of debate. The current knowledge on MCL is restricted mainly to single reports or case series with a limited number of larger studies. Our aim is to provide a comprehensive overview of this rare disease in terms of clinical manifestations, morphology, phenotype, molecular characteristics, differential diagnosis, outcome and treatment. A general overview on mastocytosis is also included.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Pathology Unit, Azienda USL-IRCCS di Reggio Emilia, 42123 Reggio Emilia, Italy.
- Hematology, Centro di Ricerca Emato-Oncologica-C.R.E.O., University of Perugia, 06129 Perugia, Italy.
- Pathology Unit, Ospedale SS Annunziata di Taranto, 74121 Taranto, Italy.
- Hematology Unit, Presidio Ospedaliero S.G. Moscati di Taranto, 74010 Taranto, Italy.
- Surgical Oncology Unit, Azienda USL-IRCCS di Reggio Emilia, 42123 Reggio Emilia, Italy.
- Pathology Unit, Policlinico Riuniti, University of Foggia, 71122 Foggia, Italy.
ORCID-Profile: Magda Zanelli, Andrea Palicelli, Maurizio Zizzo, Stefano Ricci, Giuseppe Broggi, Rosario Caltabiano, Paola Parente
Zitieren
APA
Zanelli, M., Quintini, M., Magnasco, S., Aprile, L., Palicelli, A., Zizzo, M., Sanguedolce, F., Ricci, S., Pancetti, S., Zuccalà, V., Martino, V., Broggi, G., Caltabiano, R., Cavazza, A., Parente, P., Mecucci, C., Martino, G., & Ascani, S. (2023). Mast Cell Leukemia: An Update with a Practical Review. Cancers, 15(6), 1664. https://doi.org/10.3390/cancers15061664
Vancouver
Zanelli M, Quintini M, Magnasco S, Aprile L, Palicelli A, Zizzo M, et al. Mast Cell Leukemia: An Update with a Practical Review. Cancers. 2023;15(6):1664. doi:10.3390/cancers15061664
BibTeX
@article{Zanelli2023,
author = {Zanelli, Magda and Quintini, Martina and Magnasco, Salvatore and Aprile, Lara and Palicelli, Andrea and Zizzo, Maurizio and Sanguedolce, Francesca and Ricci, Stefano and Pancetti, Saverio and Zuccalà, Valeria and Martino, Veronica and Broggi, Giuseppe and Caltabiano, Rosario and Cavazza, Alberto and Parente, Paola and Mecucci, Cristina and Martino, Giovanni and Ascani, Stefano},
title = {Mast Cell Leukemia: An Update with a Practical Review},
journal = {Cancers},
year = {2023},
volume = {15},
number = {6},
pages = {1664},
doi = {10.3390/cancers15061664}
}
EUVIMED